Enterprise Value
-51.24M
Cash
78.84M
Avg Qtr Burn
-9.394M
Short % of Float
0.99%
Insider Ownership
38.49%
Institutional Own.
11.75%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SNS-101 Details Cancer, Solid tumor/s | Phase 1/2 Data readout | |
SNS-301 Details Head and neck cancer, Cancer, Head and neck squamous cell carcinoma | Failed Discontinued | |
SNS-401-NG Details Cancer, Carcinoma | Failed Discontinued |